Aytu Biopharma Inc (AYTU) Inventory Turnover Ratio, from fourth quarter 2026 to fourth quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Aytu Biopharma Inc  (NASDAQ: AYTU)
 

Aytu Biopharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aytu Biopharma Inc inventory turnover ratio, the Aytu Biopharma Inc's ability to sell and replace its inventory in the fourth quarter 2026, sequentially increased to 2.09 in the fourth quarter 2026, AYTU's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Aytu Biopharma Inc in Jun 30 2026 quarter, has decreased to 175 days, compare to 194 days, in the Mar 31 2026 quarter.

Within Healthcare sector 191 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1456 in the third quarter 2026, to 1615.

AYTU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aytu Biopharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AYTU Inventory Turnover Ratio (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Inventory Growth -40 % -32.54 % -9.49 % -13.96 % -9.49 %
Y / Y Cost of Sales Growth -5.05 % -20 % 0 % 0 % -1.15 %
Inventory Turnover Ratio (TTM) 2.09 1.88 1.82 1.77 1.71
AYTU's Total Ranking # 1615 # 1456 # 1408 # 1408 # 1444
Average inventory processing period 175 194 201 206 214
Seq. Inventory Growth -8.04 % -34.76 % 13.21 % -11.67 % 3.4 %
Seq. Cost of Sales Growth 42.43 % -20 % 25 % -33.33 % 20 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 53
Healthcare Sector # 192
Overall Market # 1615

Inventory Turnover Ratio Statistics
High Average Low
3.38 2.06 0.9
(Dec 31 2022)   (Sep 30 2015)



AYTU Company Profile >> Back to AYTU Efficiency Comparisons >> Compare AYTU Inventory Turnover Ratio to its Competitors

Financial Statements
Aytu Biopharma Inc's Inventories $ 7 Millions Visit AYTU's Balance sheet
Aytu Biopharma Inc's Cost of Revenues TTM $ 19 Millions Visit AYTU's Income Statement
What are AYTU's Sales? Visit AYTU's Sales by Segment

Other Inventory Turnover Ratios
Aytu Biopharma Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AYTU's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AYTU's Competitors
Inventory Turnover Ratio for AYTU's Suppliers
Inventory Turnover Ratio for AYTU's Customers

You may also want to know
AYTU's Sales Growth Rates AYTU's Pe Price to earnings ratio AYTU's Receivables Turnover Ratio AYTU's Stock Quote
AYTU's Net Income Growth Rates AYTU's Ps Price to Sales ratio AYTU's Sales per Employee AYTU's Asset Turnover Ratio
AYTU's Net Margin AYTU's Pb Price to Book ratio AYTU's Financial Strength Ratios AYTU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions

Date modified: 2026-09-26T08:02:23+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.